Breaking News

Tweet TWEET

New Collaboration Between CCRM and Nikon to Reap Benefits

New Collaboration Between CCRM and Nikon to Reap Benefits Outside the
Lab 
TORONTO, ONTARIO -- (Marketwire) -- 01/15/13 -- The Centre for
Commercialization of Regenerative Medicine (CCRM) has entered into an
agreement with Nikon Corporation to place the Nikon BioStation CT
Integrated Cell Culture Observation System, and related software, in
CCRM's product development facility to perform high throughput
studies of patient-derived stem cell responsiveness to test molecules
in a controlled environment. Together, CCRM and Nikon will develop
new algorithms necessary to capture cellular and molecular events as
they unfold. The end result will be the generation of crucial data
that should help advance personalized regenerative medicine.  
"This collaboration is an exciting initiative that will have multiple
benefits for CCRM and its industry consortium," says Dr. Peter
Zandstra
, CSO of CCRM and Professor of Biomedical Engineering at the
University of Toronto. "The studies we will undertake are well
aligned with our efforts to standardize metrics in stem cell
responses. The equipment will enable us to image plated cells and
perform analyses regularly over a 24-hour period, thereby allowing
CCRM scientists to recognize when crucial changes are happening to
the cells, in real time. This is particularly significant when
testing how cells react to drugs or genes." 
Continues Dr. Zandstra, "Of note, the open interaction with Nikon,
including co-development efforts of next generation imaging
algorithms, should have broad impact for the research community. CCRM
is excited to lead this collaboration." 
CCRM has a fully resourced, 6,000 square foot development facility
focused on cell reprogramming and engineering; cell manufacturing;
and, biomaterials and devices.  
About the Centre for Commercialization of Regenerative Medicine
(CCRM)  
CCRM, a Canadian not-for-profit organization funded by the Government
of Canada's Networks of Centres of Excellence program and six
academic partners, supports the development of technologies that
accelerate the commercialization of stem cell- and biomaterials-based
technologies and therapies. A network of academics, industry and
entrepreneurs, CCRM aims to translate scientific discoveries into
marketable products for patients. CCRM launched in T
oronto's
Discovery District on June 14, 2011. CCRM is hosted by the University
of Toronto.
Contacts:
Centre for Commercialization of Regenerative Medicine
Stacey Johnson
Manager, Communications
647-309-1830
stacey.johnson@ccrm.ca
www.ccrm.ca
 
 
Press spacebar to pause and continue. Press esc to stop.